Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 45 out of 100. Lewy body dementia

Topic: Amyloid, tau and blood-test diagnosis

Plain-language summary

Mixed dementia is caused most often by the coexistence of Alzheimer's disease (AD) and vascular dementia (VaD) pathologies. This disease presents challenges due to its complex, dual pathology. In this review, we summarize the current understanding of the pathophysiology of AD and VaD, with a particular emphasis on vascular factors that accelerate or exacerbate AD pathology. We then describe animal models, in vitro cell culture systems, and brain organoid models that have been developed or are currently being developed to elucidate the neurodegenerative and vascular components of MD. This review provides an evaluation of the panorama of factors that influence MD pathophysiology and how basic science models can incorporate these factors to advance the knowledge related to the mechanisms of the disease and guide the screening of novel therapeutic approaches.

What this study adds

Evidence grade: Low

This review summarizes the pathophysiology of mixed Alzheimer's disease and vascular dementia and describes animal, cell culture and brain organoid models used to study it. It reports no findings on treating, curing or preventing Alzheimer's disease.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Sarhan, M., Wohlfeld, C., Perry-Mills, A., Meyers, J. B., Fadel, J. G., Murphy, E. A., et al. (2025). The pathophysiology of mixed Alzheimer's disease and vascular dementia. Theranostics. https://doi.org/10.7150/thno.118737

Vancouver

Sarhan M, Wohlfeld C, Perry-Mills A, Meyers JB, Fadel JG, Murphy EA, et al. The pathophysiology of mixed Alzheimer's disease and vascular dementia. Theranostics. 2025. doi:10.7150/thno.118737. PMID: 41041058.

BibTeX

@article{sarhan2025-41041058,
  author  = {Sarhan, Mutaz and Wohlfeld, Christian and Perry-Mills, Ariel and Meyers, Jeffrey B. and Fadel, James G. and Murphy, E. Angela and Bonilha, Leonardo and Fan, Daping},
  title   = {{The pathophysiology of mixed Alzheimer's disease and vascular dementia}},
  journal = {Theranostics},
  year    = {2025},
  doi     = {10.7150/thno.118737},
  pmid    = {41041058},
  url     = {https://doi.org/10.7150/thno.118737}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

Key findings

Why it matters

This review summarizes the pathophysiology of mixed Alzheimer's disease and vascular dementia and describes animal, cell culture and brain organoid models used to study it. It reports no findings on treating, curing or preventing Alzheimer's disease.

Study details

How this study scored 45/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 3 of 7; Citations per year 2 of 5; Impact for its field and year 4 of 6; Cited by studies here 2 of 6; Still being cited 2 of 4; Senior author's track record 3 of 4; Institution's track record 1 of 3; Multicenter collaboration 0 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 45 of 100.45 of 100 points earned55 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Theranostics)
Journal's citation record 2 / 4 Theranostics: journal h-index 228 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 3 / 7 Cited 22 times (OpenAlex, 2026-10-10)
Citations per year 2 / 5 7.3 citations a year over 3 year(s) since 2025
Impact for its field and year 4 / 6 Cited 12.1× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 2 / 6 Cited by 4 other studies in this library
Still being cited 2 / 4 Cited 22 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 3 / 4 Last-listed author Daping Fan: h-index 51 (OpenAlex, whole career)
Institution's track record 1 / 3 University of South Carolina: institution h-index 712 (OpenAlex)
Multicenter collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41041058)
Free to read 2 / 2 Free to read
Total 45 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Later studies that cite this one

4 studies in the alzhub library list this one in their references.

Related studies in Lewy body dementia from nearby years

Also in Lewy body dementia

39 studies in the library are filed under Lewy body dementia with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Lewy body dementia hub.

Similar studies

More on Lewy body dementia

See all studies in Lewy body dementia →